{"count": 4, "results": [{"_id": "35935880", "pmid": 35935880, "pmcid": "PMC9355151", "title": "Metformin's effects on varicocele, erectile dysfunction, infertility and prostate-related diseases: A retrospective cohort study", "journal": "Front Pharmacol", "authors": ["Tseng CH"], "date": "2022-07-22T00:00:00Z", "doi": "10.3389/fphar.2022.799290", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "799290", "score": 50271.48, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@'s effects on @DISEASE_Varicocele @DISEASE_MESH:D014646 @@@varicocele@@@, @DISEASE_Erectile_Dysfunction @DISEASE_MESH:D007172 @@@erectile dysfunction@@@, @DISEASE_Infertility @DISEASE_MESH:D007246 @@@infertility@@@ and @<m>DISEASE_Prostatic_Diseases</m> @DISEASE_MESH:D011469 @@@prostate-related diseases@@@: A retrospective cohort study", "citations": {"NLM": "Tseng CH. Metformin's effects on varicocele, erectile dysfunction, infertility and prostate-related diseases: A retrospective cohort study Front Pharmacol. 2022;13():799290. PMID: 35935880", "BibTeX": "@article{35935880, title={Metformin's effects on varicocele, erectile dysfunction, infertility and prostate-related diseases: A retrospective cohort study}, author={Tseng CH}, journal={Front Pharmacol}, volume={13}, pages={799290}}"}}, {"_id": "29117997", "pmid": 29117997, "title": "Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease?", "journal": "Am J Physiol Renal Physiol", "authors": ["Wang Z", "Olumi AF"], "date": "2018-03-01T00:00:00Z", "doi": "10.1152/ajprenal.00443.2017", "meta_date_publication": "2018 Mar 1", "meta_volume": "314", "meta_issue": "3", "meta_pages": "F407-F411", "score": 50084.066, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@: an antiproliferative agent and methylation regulator in treating @<m>DISEASE_Prostatic_Diseases</m> @DISEASE_MESH:D011469 @@@prostatic disease@@@?", "citations": {"NLM": "Wang Z, Olumi AF. Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease? Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F407-F411. PMID: 29117997", "BibTeX": "@article{29117997, title={Metformin: an antiproliferative agent and methylation regulator in treating prostatic disease?}, author={Wang Z and Olumi AF}, journal={Am J Physiol Renal Physiol}, volume={314}, number={3}, pages={F407-F411}}"}}, {"_id": "24130167", "pmid": 24130167, "title": "Metformin targets c-MYC oncogene to prevent prostate cancer.", "journal": "Carcinogenesis", "authors": ["Akinyeke T", "Matsumura S", "Wang X", "Wu Y", "Schalfer ED", "Saxena A", "Yan W", "Logan SK", "Li X"], "date": "2013-12-01T00:00:00Z", "doi": "10.1093/carcin/bgt307", "meta_date_publication": "2013 Dec", "meta_volume": "34", "meta_issue": "12", "meta_pages": "2823-32", "score": 50052.527, "text_hl": "Our results demonstrated that (i) in Hi-Myc @SPECIES_10090 @@@mice@@@ that display @SPECIES_10090 @@@murine@@@ @DISEASE_Prostatic_Intraepithelial_Neoplasia @DISEASE_MESH:D019048 @@@prostate neoplasia@@@ and highly resemble the progression of @SPECIES_9606 @@@human@@@ @DISEASE_Prostatitis @DISEASE_MESH:D011472 @@@prostate tumors@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ attenuated the development of @DISEASE_Prostatic_Intraepithelial_Neoplasia @DISEASE_MESH:D019048 @@@prostate intraepithelial neoplasia@@@ (@DISEASE_Prostatic_Intraepithelial_Neoplasia @DISEASE_MESH:D019048 @@@PIN@@@, the @<m>DISEASE_Prostatic_Diseases</m> @DISEASE_MESH:D011469 @@@precancerous lesion of prostate@@@) and @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@PCa lesions@@@. ", "citations": {"NLM": "Akinyeke T, Matsumura S, Wang X, Wu Y, Schalfer ED, Saxena A, Yan W, Logan SK, Li X. Metformin targets c-MYC oncogene to prevent prostate cancer. Carcinogenesis. 2013 Dec;34(12):2823-32. PMID: 24130167", "BibTeX": "@article{24130167, title={Metformin targets c-MYC oncogene to prevent prostate cancer.}, author={Akinyeke T and Matsumura S and Wang X and Wu Y and Schalfer ED and Saxena A and Yan W and Logan SK and Li X}, journal={Carcinogenesis}, volume={34}, number={12}, pages={2823-32}}"}}, {"_id": "24599513", "pmid": 24599513, "pmcid": "PMC3978377", "title": "Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area", "journal": "Eur J Clin Pharmacol", "authors": ["Grundmark B", "Holmberg L", "Garmo H", "Zethelius B"], "date": "2014-05-01T00:00:00Z", "doi": "10.1007/s00228-014-1658-1", "meta_date_publication": "2014 May", "meta_volume": "70", "meta_issue": "5", "meta_pages": "627-35", "score": 50034.5, "text_hl": "Pilots analyzed were four different drugs for chronic disease: @CHEMICAL_bicalutamide @CHEMICAL_MESH:C053541 @@@bicalutamide@@@, @CHEMICAL_abiraterone @CHEMICAL_MESH:C089740 @@@abiraterone@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and @CHEMICAL_Vildagliptin @CHEMICAL_MESH:D000077597 @@@vildagliptin@@@, within the two therapeutic areas of @<m>DISEASE_Prostatic_Diseases</m> @DISEASE_MESH:D011469 @@@prostate gland disease@@@ and @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ (@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@).", "citations": {"NLM": "Grundmark B, Holmberg L, Garmo H, Zethelius B. Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area Eur J Clin Pharmacol. 2014 May;70(5):627-35. PMID: 24599513", "BibTeX": "@article{24599513, title={Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area}, author={Grundmark B and Holmberg L and Garmo H and Zethelius B}, journal={Eur J Clin Pharmacol}, volume={70}, number={5}, pages={627-35}}"}}]}